Siglec‐5 is an inhibitory immune checkpoint molecule for human T cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Siglec‐5 is an inhibitory immune checkpoint molecule for human T cells
Authors
Keywords
-
Journal
IMMUNOLOGY
Volume 166, Issue 2, Pages 238-248
Publisher
Wiley
Online
2022-03-16
DOI
10.1111/imm.13470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A High-Throughput Method for Identifying Novel Genes That Influence Metabolic Pathways Reveals New Iron and Heme Regulation in Pseudomonas aeruginosa
- (2021) David G. Glanville et al. mSystems
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches
- (2018) Kathryn A. Patras et al. Frontiers in Pediatrics
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
- (2018) Joyce Lübbers et al. Frontiers in Immunology
- Group BStreptococcusInduces a Robust IFN-γResponse by CD4+T Cells in anIn VitroandIn VivoModel
- (2016) Damian Clarke et al. Journal of Immunology Research
- Bright Fluorescent Streptococcus pneumoniae for Live-Cell Imaging of Host-Pathogen Interactions
- (2014) Morten Kjos et al. JOURNAL OF BACTERIOLOGY
- Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group BStreptococcus
- (2014) Syed Raza Ali et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
- (2012) Tadashi Yokosuka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells
- (2012) Paula C. Soto et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cell Surface Signaling Molecules in the Control of Immune Responses: A Tide Model
- (2011) Yuwen Zhu et al. IMMUNITY
- Human Siglec-5 Inhibitory Receptor and Immunoglobulin A (IgA) Have Separate Binding Sites in Streptococcal β Protein
- (2011) Therése Nordström et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
- Group BStreptococcussuppression of phagocyte functions by protein-mediated engagement of human Siglec-5
- (2009) Aaron F. Carlin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CTLA-4 trafficking and surface expression
- (2008) Elke Valk et al. TRENDS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started